Ibrahim Akkari, DPM
Podiatry · Lakewood
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 7 years
- New York College of Podiatric Medicine, 2019
Offices
2 locations · Ibrahim Akkari Dpm · Rory J Friedman Dpm A Podiatry Corporation
Looking this up.
Hospitals listed: Uci Health-Lakewood. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Akkari’s office to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Uci Health-LakewoodLakewood, CAAcute Care Hospital · Proprietary · Has an emergency departmentPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 1 of 5 · 48% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.105, Oct 2024 – Sep 2025
See every measure and the patient survey for Uci Health-Lakewood
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.105 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.94 (0 to 1.97) · 512 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.15 (0.77 to 1.53) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.76 (139.14 to 246.38) · 35 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.4 · 57 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.8 · 149 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.2 · 264 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.5 · 223 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,866 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.51) · 3,098 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,262 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.33 to 6.11) · 498 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.91 (1.29 to 4.53) · 492 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.25 (1.53 to 20.97) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.91 (0.24 to 1.58) · 2,875 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 89 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.584 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.28 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.498 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.265 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 181 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.3 · 403 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.3 · 56 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 32.6 · 184 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 89.6 · 289 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 495 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.8 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12 · 70 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.5 to 17.5) · 95 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.2) · 80 cases | No different | Jan 2024 – Dec 2024 |
What patients said (391 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 1 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 2 |
| Overall hospital rating | 1 |
| Quietness | 1 |
| Recommend hospital | 1 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 66% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 78% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 75% |
| Patients who gave a rating of "9" or "10" (high) | 49% |
| Staff "always" explained new medications | 63% |
| Nurses "always" explained things so they could understand | 60% |
| Nurses "always" listened carefully | 64% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 48% |
| Staff "always" explained possible side effects | 36% |
| Yes, staff "did" give patients information about possible symptoms | 80% |
Original Medicare doctor bills
$1,024,408
Medicare paid this office $1,024,408 for 95 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of bone, 20.0 sq cm or less | 36 | $33,756 | $179 |
| Removal of bone, 20.0 sq cm or less | 21 | $20,371 | $261 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $18,990 | $65 |
| Extensive or complicated repair of surface wound reopening | 18 | $15,107 | $657 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 22 | $12,348 | $196 |
See all 15 services
| Removal of bone, 20.0 sq cm or less | 36 | $33,756 | $179 |
| Removal of bone, 20.0 sq cm or less | 21 | $20,371 | $261 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 39 | $18,990 | $65 |
| Extensive or complicated repair of surface wound reopening | 18 | $15,107 | $657 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 22 | $12,348 | $196 |
| Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | 30 | $12,097 | $336 |
| Extensive or complicated repair of surface wound reopening | 15 | $11,370 | $669 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 47 | $9,688 | $138 |
| Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | 33 | $9,578 | $213 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 21 | $7,888 | $125 |
| Short return visit (20+ min) | 47 | $7,605 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $4,487 | $98 |
| Return visit (30+ min) | 26 | $4,295 | $110 |
| New patient visit (45+ min) | 23 | $3,133 | $136 |
| Removal of fingernails or toenails, 6 or more nails | 14 | $586 | $37 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Removal of nail tissue | 855 | More than 90% of doctors who do this |
| Removal of skin lesions | 198 | More than 79% of doctors who do this |
| Removal of tissue | 265 | More than 93% of doctors who do this |
| Removal or shaving of skin growth | 348 | More than 93% of doctors who do this |
Procedures year by year
| Procedure | 2022 | 2023 | 2024 |
|---|---|---|---|
| Removal of bone, 20.0 sq cm or less | – | 111 | 267 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | – | 86 | 126 |
| Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | – | 47 | 81 |
| Extensive or complicated repair of surface wound reopening | – | 13 | 40 |
| Removal of fingernails or toenails, 6 or more nails | – | – | 16 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
95 Original Medicare patients in 2024. Average age 70 · Women 45% · Also on Medicaid 66% · Health risk score 3.79. Sicker patients than 9 in 10 peers; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 69% · Heart failure 47% · Chronic kidney disease 47% · Coronary heart disease 39% · COPD 29% · Atrial fibrillation 28% · Depression 27% · Stroke 22% · Dementia 20%.
The office billed $1,617,527, Medicare allowed $1,287,003 and paid $1,024,408; for 1,758 services of 65 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 95 | 1,758 | 70 | 3.79 | $1,617,527 | $1,024,408 |
| 2023 | 72 | 2,106 | 74 | 4.81 | $1,801,761 | $1,213,320 |
| 2022 | 34 | 147 | 71 | 2.88 | $46,480 | $14,890 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Removal of bone, 20.0 sq cm or less | 27 | $20,079 | $181 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $13,921 | $66 |
| Removal of muscle and/or tissue, 20.0 sq cm or less | 33 | $11,034 | $128 |
| Preparation of skin graft site of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 100.0 sq cm or 1% body area for infants and children, or less | 39 | $10,239 | $218 |
| Extensive or complicated repair of surface wound reopening | 11 | $8,473 | $652 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 38 | $6,974 | $145 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,265 | $109 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,592 | $100 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $2,569 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,811 | $113 |
| Short return visit (20+ min) | 17 | $1,282 | $75 |
Medicaid work
$997 in 2024
Medicaid paid $997 for 41 billed services this clinician did in 2024, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 29 | $600 |
| 1ST HOSP IP/OBS HIGH 75 | 12 | $397 |
| 2024 | 41 | 2 | 13 | $997 |
Drugs they prescribed that Part D paid
$8,835
Pharmacies billed $8,835 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 8% of their Part D prescriptions (32 of 409) in 2024. Above the middle of the specialty; the typical podiatry clinician is at 5%.
403 generic and fewer than 11 brand-name prescriptions · $8,835 in drug cost · 46 antibiotic prescriptions to 36 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ketoconazole | 49 | $1,541 | $18 |
| Ammonium Lactate | 62 | $1,501 | $17 |
| Gabapentin | 27 | $419 | $11 |
| Terbinafine | 14 | $350 | $23 |
| Hydrocodone-Acetaminophen | 11 | $173 | $12 |
See all 9 drugs
| Ketoconazole | 49 | $1,541 | $18 |
| Ammonium Lactate | 62 | $1,501 | $17 |
| Gabapentin | 27 | $419 | $11 |
| Terbinafine | 14 | $350 | $23 |
| Hydrocodone-Acetaminophen | 11 | $173 | $12 |
| Methylprednisolone | 36 | $172 | $4 |
| Cefdinir | 18 | $147 | $8 |
| Doxycycline Hyclate | 11 | $143 | $9 |
| Meloxicam | 11 | $40 | $2 |
Year by year
| 2024 | 409 | 226 | 8% (32) | None | $8,835 |
| 2023 | 86 | 55 | 16% (14) | None | $13,937 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Ketoconazole | 14 | $595 | $42 |
| Gabapentin | 13 | $88 | $7 |
| Methylprednisolone | 12 | $86 | $7 |
Money from drug and device companies
$34 in 2025
| 2025 | 1 | 2 | None | $34 |
| 2024 | 5 | 8 | None | $284 |
| 2023 | 14 | 23 | None | $1,170 |
| 2022 | 9 | 16 | None | $489 |
| 2021 | 3 | 4 | None | $171 |
| 2020 | 4 | 4 | None | $128 |
| 2019 | 3 | 6 | None | $355 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Integra LifeSciences | Integra | $34 | 2 payments
|
See all 2 published payments
| Integra LifeSciences | Meals · 2025-12-17 | Integra | $17 |
| Integra LifeSciences | Meals · 2025-08-26 | Integra | $18 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $284
| Linvatec | Biobrace 23mm | $151 | 1 payment
|
| Integra LifeSciences | Integra | $58 | 3 payments
|
| IBSA Pharma | Tirosint | $31 | 2 payments
|
| Stryker | Infinity Adaptis | $30 | 1 payment
|
| International Life Sciences | Flexband | $15 | 1 payment
|
2023: $1,170
| Medical Device Business Services | None | $609 | 4 payments
|
| Arthrex | None | $176 | 3 payments
|
| Globus Medical | Mini Fragment System | $73 | 2 payments
|
| Integra LifeSciences | Integra | $60 | 2 payments
|
| Biotissue Holdings | Neox | $52 | 2 payments
|
| DePuy Synthes Sales | Crosstie | $46 | 2 payments
|
| Kci USA | Prevena | $37 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $20 | 1 payment
|
| Medline Industries Lp | Medline Industries, Inc. | $20 | 1 payment
|
| Abbott Laboratories | Proclaim | $19 | 1 payment
|
| Orpyx Medical Technologies US | Orpyx Si | $18 | 1 payment
|
| Ethicon US | Dermabond | $16 | 1 payment
|
| Kowa Pharmaceuticals America | Seglentis | $13 | 1 payment
|
| Smith+Nephew | Renasys Go V2 Home | $13 | 1 payment
|
2022: $489
| Integra LifeSciences | Integra | $281 | 7 payments
|
| Saxum Surgical | None | $43 | 2 payments
|
| Treace Medical Concepts | Lapiplasty System | $41 | 1 payment
|
| Kci USA | V.A.C. Dermatac | $30 | 1 payment
|
| Smith+Nephew | Grafix | $27 | 1 payment
|
| Carlsmed | Aprevo | $24 | 1 payment
|
| Kowa Pharmaceuticals America | Seglentis | $18 | 1 payment
|
| Medline Industries Lp | Medline Industries, Inc. | $13 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $12 | 1 payment
|
2021: $171
| Smith+Nephew | Stravix | $90 | 2 payments
|
| Zimmer Biomet Holdings | Stratum Foot Plating System | $62 | 1 payment
|
| Globus Medical | Ankle Fracture System | $19 | 1 payment
|
2020: $128
| Integra LifeSciences | Flowable | $39 | 1 payment
|
| Zimmer Biomet Holdings | Stratum Foot Plating System | $37 | 1 payment
|
| Stryker | Allowrap | $37 | 1 payment
|
| Paragon 28 | None | $15 | 1 payment
|
2019: $355
| Wright Medical Technology | Cartiva | $143 | 2 payments
|
| Zimmer Biomet Holdings | Accufill | $115 | 2 payments
|
| Integra LifeSciences | Omnigraft | $97 | 2 payments
|
Professional record
- NPI
- 1851954523
- Licence
- CA EL6902
- Trained
- New York College of Podiatric Medicine, 2019 · 7 years ago
- Group
- Ibrahim Akkari Dpm · Rory J Friedman Dpm A Podiatry Corporation
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X); Federal specialty code 213E00000X (213E00000X)
- Mailing address
- 301 S Fair Oaks Ave Ste 207, Pasadena, CA, 91105
- NPI first listed
- 2019-04-18
- NPI last updated
- 2026-07-13
- NPI record certified
- 2026-07-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 391 Hylan Blvd, Staten Island, NY, 10305